Patents by Inventor Jean-Michel Luccarini

Jean-Michel Luccarini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10383858
    Abstract: The invention relates to the use of a pan-PPAR agonist, or of a pharmaceutical composition containing said agonist, for the treatment of a fibrotic condition.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: August 20, 2019
    Assignee: INVENTIVA
    Inventors: Irena Konstantinova, Jean-Michel Luccarini, Jean-Louis Junien, Pierre Broqua
  • Publication number: 20180333396
    Abstract: The invention relates to the use of a pan-PPAR agonist, or of a pharmaceutical composition containing said agonist, for the treatment of a fibrotic condition.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 22, 2018
    Inventors: Irena KONSTANTINOVA, Jean-Michel LUCCARINI, Jean-Louis JUNIEN, Pierre BROQUA
  • Patent number: 10052311
    Abstract: The invention relates to the use of a pan-PPAR agonist, or of a pharmaceutical composition containing said agonist, for the treatment of a fibrotic condition.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: August 21, 2018
    Assignee: INVENTIVA
    Inventors: Irena Konstantinova, Jean-Michel Luccarini, Jean-Louis Junien, Pierre Broqua
  • Publication number: 20170189383
    Abstract: The invention relates to the use of a pan-PPAR agonist, or of a pharmaceutical composition containing said agonist, for the treatment of a fibrotic condition.
    Type: Application
    Filed: June 12, 2015
    Publication date: July 6, 2017
    Inventors: Irena KONSTANTINOVA, Jean-Michel LUCCARINI, Jean-Louis JUNIEN, Pierre BROQUA
  • Patent number: 7538111
    Abstract: The present invention concerns novel benzenesulphonamide compounds, defined by formula I. Therapeutic compositions comprising the benzenesulphonamide compounds of the invention or salts thereof and methods for producing the benzenesulphonamide compounds of the invention are also disclosed. The benzenesulphonamide compounds of the invention or salts thereof are useful for treating pain, such as hyperalgesia and major algesia.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: May 26, 2009
    Assignee: Laboratoires Fournier S.A.
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Didier Thomas, Jean-Michel Luccarini
  • Patent number: 7361687
    Abstract: The present invention relates to novel arylsulphonamide compounds, defined by formula I and the description, as well as their method of preparation and their therapeutic use
    Type: Grant
    Filed: June 12, 2003
    Date of Patent: April 22, 2008
    Assignee: Laboratoires Fournier SA
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Jean-Michel Luccarini
  • Publication number: 20060178360
    Abstract: The present invention concerns novel benzenesulphonamide compounds, defined by formula I and the description, their method of preparation and their use in therapy.
    Type: Application
    Filed: March 24, 2004
    Publication date: August 10, 2006
    Applicant: Laboratoires Fournier S.A.
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Didier Thomas, Jean-Michel Luccarini
  • Publication number: 20060084699
    Abstract: The present invention relates to novel arylsulphonamide compounds, defined by formula I and the description, as well as their method of preparation and their therapeutic use.
    Type: Application
    Filed: June 12, 2003
    Publication date: April 20, 2006
    Inventors: Martine Barth, Michel Bondoux, Pierre Dodey, Christine Massardier, Jean-Michel Luccarini
  • Publication number: 20040063725
    Abstract: The present invention relates to novel N-(phenylsulphonyl)glycyl-glycine compounds, which are defined by formula I and the description, as well as their method of preparation and their use in therapeutics 1
    Type: Application
    Filed: June 20, 2003
    Publication date: April 1, 2004
    Inventors: Martine Barth, Michel Bondoux, Christophe Matt, Pierre Dodey, Jean-Michel Luccarini, Jean-Luc Paquet, Didier Pruneau
  • Patent number: 6316413
    Abstract: The invention concerns a pseudopeptide compounds selected among the set constituted by: (i) the compounds of formula (I): in which: A1 represents a single bond, D-Arg or L-Lys; A2 represents L-Pro or trans-4-hydroxy-L-Pro (4Hyp); A3 represents L-Phe or L-thienylalanine (Thi); Y represents a hydrogen atom or a C1-C3 alkyl group; X represents a sulphur or oxygen atom; and, (ii) their additive salts. The invention also concerns the preparation and use of this compound and its additive salts in therapy.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: November 13, 2001
    Assignee: Fournier Industrie et Sante
    Inventors: Pierre Dodey, Jean-Michel Luccarini, Jean Martinez, Muriel Amblard, Isabelle Daffix